| 28 Aug, 08:59 pm | — | … | Biocon Limited has informed the Exchange about "Communication regarding remittance of final dividend for the FY 2025-26" | nse |
| 26 Aug, 02:51 pm | — | … | Biocon Ltd - 532523 - Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 25 Aug, 08:28 am | — | … | Biocon Limited has informed the Exchange regarding 'Company Statement'. | nse |
| 18 Aug, 08:40 am | — | … | Biocon Limited has informed the Exchange regarding 'Company Statement'. | nse |
| 11 Aug, 08:03 pm | — | … | Biocon Limited has informed the Exchange about Transcript | nse |
| 11 Aug, 07:49 pm | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 06 Aug, 11:26 pm | — | … | Biocon Limited has informed the Exchange regarding resignation of Ms BSR Co & LLP Statutory Auditors of the material subsidiary of the Company w.e.f. August 06, 2026. | nse |
| 06 Aug, 11:15 pm | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors | bse |
| 06 Aug, 09:11 pm | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 06 Aug, 09:09 pm | — | … | Biocon Ltd - 532523 - Completion Of Tenure Of Statutory Auditors | bse |
| 06 Aug, 09:08 pm | — | … | Biocon Limited has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 06 Aug, 09:07 pm | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | bse |
| 06 Aug, 09:04 pm | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 06 Aug, 09:04 pm | — | … | Biocon Limited has informed the Exchange regarding Change in Auditors of the company. | nse |
| 06 Aug, 08:59 pm | — | … | Biocon Limited has informed the Exchange regarding Re-appointment of Mr Erick Mazumdar as Non- Executive Director of the company w.e.f. August 06, 2026. | nse |
| 06 Aug, 06:43 pm | — | … | Biocon Limited has informed the Exchange about Link of Recording | nse |
| 06 Aug, 06:42 pm | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 06 Aug, 07:22 am | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 06 Aug, 07:21 am | — | … | Biocon Limited has informed the Exchange about Investor Presentation | nse |
| 05 Aug, 05:09 pm | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report | bse |
| 05 Aug, 05:08 pm | — | … | Monitoring Agency Report for the quarter ended on June 30, 2026 | nse |
| 05 Aug, 05:02 pm | — | … | Biocon Limited has informed the Exchange regarding a press release dated August 05, 2026, titled "Biocon Q1FY27 Total Income at Rs 4,391 Cr, Up 9%; EBITDA at Rs 902 Cr; Net Profit at Rs 141 Cr; Biopharma Revenue Up 17%". | nse |
| 05 Aug, 05:01 pm | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 05 Aug, 04:59 pm | — | … | Biocon Ltd - 532523 - Board Meeting Outcome for Outcome Of Board Meeting | bse |
| 05 Aug, 04:54 pm | — | … | Biocon Ltd - 532523 - Outcome Of Board Meeting-Financial Results | bse |
| 05 Aug, 04:51 pm | — | … | Biocon Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. | nse |
| 03 Aug, 08:28 am | — | … | Biocon Limited has informed the Exchange regarding a press release dated August 03, 2026, titled "Biocon Announces U.S. Commercial Launch of Yesafili , a Biosimilar to Regeneron s Eylea® 2 mg". | nse |
| 03 Aug, 08:26 am | — | … | Biocon Limited has informed the Exchange about Commercial Launch of Product | nse |
| 03 Aug, 08:24 am | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 29 Jul, 08:31 am | — | … | Biocon Limited has informed the Exchange regarding 'Company Statement'. | nse |
| 28 Jul, 08:01 pm | — | … | Biocon Ltd - 532523 - Board Meeting Intimation for Intimation For The Board Meeting And Earnings Conference Call For Analysts And Investors | bse |
| 28 Jul, 12:31 pm | — | … | Mylan Inc. has Submitted to the Exchange a copy of Disclosure under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 22 Jul, 08:02 pm | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 22 Jul, 07:51 pm | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 22 Jul, 07:50 pm | — | … | Biocon Limited has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 16 Jul, 08:43 am | — | … | Biocon Limited has informed the Exchange regarding 'Company Statement'. | nse |
| 15 Jul, 03:24 pm | — | … | Biocon Ltd - 532523 - Reg. 34 (1) Annual Report. | bse |
| 15 Jul, 01:24 pm | — | … | Biocon Ltd - 532523 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 09 Jul, 08:45 am | — | … | Biocon Limited has informed the Exchange regarding a press release dated July 09, 2026, titled " Biocon Announces Publication of Pivotal Clinical Data Supporting Effectiveness of Yesafili , a Biosimilar to Eylea® (Aflibercept) ". | nse |
| 09 Jul, 08:41 am | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 29 Jun, 11:22 pm | — | … | Biocon Limited has informed the Exchange regarding allotment of 8786362 securities pursuant to Preferential Issue at its meeting held on Jun 29, 2026 | nse |
| 29 Jun, 10:51 pm | — | … | Biocon Limited has informed the Exchange about Acquisition | nse |
| 29 Jun, 10:35 pm | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Updates on Acquisition | bse |
| 29 Jun, 10:33 pm | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Allotment | bse |
| 24 Jun, 08:34 am | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 24 Jun, 08:33 am | — | … | Biocon Limited has informed the Exchange regarding a press release dated Jun 24, 2026, titled "Biocon Reinforces Commitment to Diabetes Care in Malaysia as Partner Duopharma Biotech Secures Insulin Tenders". | nse |
| 22 Jun, 07:37 pm | — | … | Biocon Limited has informed the Exchange about Communication to the shareholders w.r.t. TDS on Final Dividend | nse |
| 15 Jun, 07:12 pm | — | … | Kiran Mazumdar-Shaw has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 | nse |
| 10 Jun, 07:50 pm | m_and_a | 2 | Biocon Limited informed the exchange about an acquisition, but the announcement text provided does not include the target, consideration, or stake size. | nse |
| 01 Jun, 08:31 am | — | … | Biocon Limited has informed the Exchange about Investor Presentation | nse |